Manila, 27 March 2014 – Finally, we can put a stop to this daily discomfort in our lives. GlaxoSmithKline, in collaboration with the Philippine Dental Association (PDA), is embarking on the advocay to fight against sensitive teeth/pangingilo in the “Say No to Ngilo!” campaign. This remarkable commitment extends beyond a mere information campaign and toward proactive efforts to improve oral health care in the country, including the help of 2,000 dentists who have committed to the fight against dentine hypersensitivity through educating their patients on proper oral hygiene and using effective tools to combat pangingilo.
“GlaxoSmithKline, through our brand, Sensodyne, has provided solutions to Filipinos for sensitive teeth. Sensodyne is the number-one sensitivity brand in the market, and most recommended brand by dentists for pangingilo. In GSK’s commitment to make every Filipino sensitivity-free, GSK launches Sensodyne sachets for only PhP10 to drive accessibility and affordability for the solution to pangingilo.
“The Philippines is the first country in the world where Sensodyne is introducing the sachet format. This development is also significant because GSK is confident of the Philippines as an important emerging market, and this will definitely encourage more Filipinos to proactively manage their sensitive teeth and say no to ngilo,” says Jeoffrey Yulo, Consumer Healthcare General Manager, GSK Philippines.
Sensodyne has continually provided clinically proven relief from pangingilo, more experts recommend Sensodyne. If you have pangingilo, switching to Sensodyne to replace your regular toothpaste can make a big difference not only in your enjoyment of everyday life, but also in your overall oral health.